Cargando…
COVID-19 and cancer screening in Scotland: A national and coordinated approach to minimising harm
Screening is an important component of cancer control internationally. In Scotland, the National Health Service Scotland provides screening programmes for cervical, bowel and breast cancers. The COVID-19 pandemic resulted in the suspension of these programmes in March 2020. We describe the integrate...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241681/ https://www.ncbi.nlm.nih.gov/pubmed/34217418 http://dx.doi.org/10.1016/j.ypmed.2021.106606 |
_version_ | 1783715464838381568 |
---|---|
author | Campbell, Christine Sommerfield, Tasmin Clark, Gavin R.C. Porteous, Lorna Milne, Alison M. Millar, Rosemary Syme, Tracey Thomson, Catherine S. |
author_facet | Campbell, Christine Sommerfield, Tasmin Clark, Gavin R.C. Porteous, Lorna Milne, Alison M. Millar, Rosemary Syme, Tracey Thomson, Catherine S. |
author_sort | Campbell, Christine |
collection | PubMed |
description | Screening is an important component of cancer control internationally. In Scotland, the National Health Service Scotland provides screening programmes for cervical, bowel and breast cancers. The COVID-19 pandemic resulted in the suspension of these programmes in March 2020. We describe the integrated approach to managing the impact of the pandemic on cancer screening programmes in Scotland throughout 2020. We outline the policy context and decision-making process leading to suspension, and the criteria and framework informing the subsequent, staggered, restart in subsequent months. The decision to suspend screening services in order to protect screening invitees and staff, and manage NHS capacity, was made after review of numbers of screening participants likely to be affected, and the potential number of delayed cancer diagnoses. Restart principles and a detailed route map plan were developed for each programme, seeking to ensure broad consistency of approach across the programmes and nationally. Early data indicates bowel, breast and cervical screening participation has increased since restart. Primary care has had to adapt to new infection prevention control measures for delivery of cervical screening. Cancer charities provided cancer intelligence and policy briefs to national bodies and Scottish Government, as well as supporting the public, patients and screening invitees through information and awareness campaigns. Emerging from the pandemic, there is recognition of the need and the opportunity to transform and renew both cancer and screening services in Scotland, and in particular to address long-standing workforce capacity problems through innovation and investment, and to continue to prioritise addressing health inequalities. |
format | Online Article Text |
id | pubmed-8241681 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-82416812021-07-01 COVID-19 and cancer screening in Scotland: A national and coordinated approach to minimising harm Campbell, Christine Sommerfield, Tasmin Clark, Gavin R.C. Porteous, Lorna Milne, Alison M. Millar, Rosemary Syme, Tracey Thomson, Catherine S. Prev Med Article Screening is an important component of cancer control internationally. In Scotland, the National Health Service Scotland provides screening programmes for cervical, bowel and breast cancers. The COVID-19 pandemic resulted in the suspension of these programmes in March 2020. We describe the integrated approach to managing the impact of the pandemic on cancer screening programmes in Scotland throughout 2020. We outline the policy context and decision-making process leading to suspension, and the criteria and framework informing the subsequent, staggered, restart in subsequent months. The decision to suspend screening services in order to protect screening invitees and staff, and manage NHS capacity, was made after review of numbers of screening participants likely to be affected, and the potential number of delayed cancer diagnoses. Restart principles and a detailed route map plan were developed for each programme, seeking to ensure broad consistency of approach across the programmes and nationally. Early data indicates bowel, breast and cervical screening participation has increased since restart. Primary care has had to adapt to new infection prevention control measures for delivery of cervical screening. Cancer charities provided cancer intelligence and policy briefs to national bodies and Scottish Government, as well as supporting the public, patients and screening invitees through information and awareness campaigns. Emerging from the pandemic, there is recognition of the need and the opportunity to transform and renew both cancer and screening services in Scotland, and in particular to address long-standing workforce capacity problems through innovation and investment, and to continue to prioritise addressing health inequalities. Elsevier Inc. 2021-10 2021-06-30 /pmc/articles/PMC8241681/ /pubmed/34217418 http://dx.doi.org/10.1016/j.ypmed.2021.106606 Text en © 2021 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Campbell, Christine Sommerfield, Tasmin Clark, Gavin R.C. Porteous, Lorna Milne, Alison M. Millar, Rosemary Syme, Tracey Thomson, Catherine S. COVID-19 and cancer screening in Scotland: A national and coordinated approach to minimising harm |
title | COVID-19 and cancer screening in Scotland: A national and coordinated approach to minimising harm |
title_full | COVID-19 and cancer screening in Scotland: A national and coordinated approach to minimising harm |
title_fullStr | COVID-19 and cancer screening in Scotland: A national and coordinated approach to minimising harm |
title_full_unstemmed | COVID-19 and cancer screening in Scotland: A national and coordinated approach to minimising harm |
title_short | COVID-19 and cancer screening in Scotland: A national and coordinated approach to minimising harm |
title_sort | covid-19 and cancer screening in scotland: a national and coordinated approach to minimising harm |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241681/ https://www.ncbi.nlm.nih.gov/pubmed/34217418 http://dx.doi.org/10.1016/j.ypmed.2021.106606 |
work_keys_str_mv | AT campbellchristine covid19andcancerscreeninginscotlandanationalandcoordinatedapproachtominimisingharm AT sommerfieldtasmin covid19andcancerscreeninginscotlandanationalandcoordinatedapproachtominimisingharm AT clarkgavinrc covid19andcancerscreeninginscotlandanationalandcoordinatedapproachtominimisingharm AT porteouslorna covid19andcancerscreeninginscotlandanationalandcoordinatedapproachtominimisingharm AT milnealisonm covid19andcancerscreeninginscotlandanationalandcoordinatedapproachtominimisingharm AT millarrosemary covid19andcancerscreeninginscotlandanationalandcoordinatedapproachtominimisingharm AT symetracey covid19andcancerscreeninginscotlandanationalandcoordinatedapproachtominimisingharm AT thomsoncatherines covid19andcancerscreeninginscotlandanationalandcoordinatedapproachtominimisingharm |